We are live on ! Find out more
MTCR

Metacrine, Inc. Common Stock
MTCR

Delisted

MTCR was delisted on the 8th of February, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of MTCR yet.

MTCR Hedge Fund Activity: Q2 2023 in Review

0 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Metacrine, Inc. Common Stock (MTCR) for Q2 2023, worth a combined $0 — down 100% from $5.3M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of MTCR and 0 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BML Capital Management, exiting entirely with an estimated $3.52M sold.

  • 0 institutional investors held Metacrine, Inc. Common Stock (MTCR) as of Q2 2023, down from 5 in Q1 2023.
  • Funds reported $0 of Metacrine, Inc. Common Stock stock for Q2 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Metacrine, Inc. Common Stock positions in Q2 2023 and 5 closed out, a net change of -5 holders.
  • The largest Metacrine, Inc. Common Stock seller in Q2 2023 was BML Capital Management, an estimated $3.52M sold.

Based on aggregated 13F filings for Q2 2023.